Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / articles / NVO - Miracle Or Myth? Survey Shows Americans Doubt Ozempic Wegovy's Weight Loss Claims | Benzinga


NVO - Miracle Or Myth? Survey Shows Americans Doubt Ozempic Wegovy's Weight Loss Claims | Benzinga

A recent study by the Pew Research Center has shown that a majority of Americans are doubtful about the potential of new weight loss drugs, such as Ozempic and Wegovy, to impact the country’s obesity rate significantly.

What Happened: Despite the optimism surrounding these drugs, the majority of Americans remain skeptical, as reported by The Hill on Tuesday. The survey, conducted from Feb. 7 to Feb. 11, found that only 35% believe these drugs will somewhat reduce obesity, while 33% think they will have little to no impact.

Additionally, 65% of Americans believe that willpower alone is not enough for sustainable weight loss, suggesting a broader discussion about the role of genetics in weight loss success.

See Also: Dogecoin’s Price Patterns Mirrors 2023 Bull Market That Saw 23,000% Gains, Says Crypto Analyst: ‘We Could See DOGE Enter A Parabolic Breakout’

Over the past 20 years, the obesity rate ...

Full story available on Benzinga.com

Stock Information

Company Name: Novo Nordisk A/S
Stock Symbol: NVO
Market: NYSE
Website: novonordisk.com

Menu

NVO NVO Quote NVO Short NVO News NVO Articles NVO Message Board
Get NVO Alerts

News, Short Squeeze, Breakout and More Instantly...